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tissue specimens
Jing Chen1, Shadi Toghi Eshghi2, George Steven Bova3, Qing Kay Li1, Xingde Li2 and Hui Zhang1*Abstract
Background: The rapid advancement of high-throughput tools for quantitative measurement of proteins has
demonstrated the potential for the identification of proteins associated with cancer. However, the quantitative
results on cancer tissue specimens are usually confounded by tissue heterogeneity, e.g. regions with cancer usually
have significantly higher epithelium content yet lower stromal content.
Objective: It is therefore necessary to develop a tool to facilitate the interpretation of the results of protein
measurements in tissue specimens.
Methods: Epithelial cell adhesion molecule (EpCAM) and cathepsin L (CTSL) are two epithelial proteins whose
expressions in normal and tumorous prostate tissues were confirmed by measuring staining intensity with
immunohistochemical staining (IHC). The expressions of these proteins were measured by ELISA in protein extracts
from OCT embedded frozen prostate tissues. To eliminate the influence of tissue heterogeneity on epithelial protein
quantification measured by ELISA, a color-based segmentation method was developed in-house for estimation of
epithelium content using H&E histology slides from the same prostate tissues and the estimated epithelium per-
centage was used to normalize the ELISA results. The epithelium contents of the same slides were also estimated
by a pathologist and used to normalize the ELISA results. The computer based results were compared with the
pathologist’s reading.
Results: We found that both EpCAM and CTSL levels, measured by ELISA assays itself, were greatly affected by
epithelium content in the tissue specimens. Without adjusting for epithelium percentage, both EpCAM and CTSL
levels appeared significantly higher in tumor tissues than normal tissues with a p value less than 0.001. However,
after normalization by the epithelium percentage, ELISA measurements of both EpCAM and CTSL were in
agreement with IHC staining results, showing a significant increase only in EpCAM with no difference in CTSL
expression in cancer tissues. These results were obtained with normalization by both the computer estimated and
pathologist estimated epithelium percentage.
Conclusions: Our results show that estimation of tissue epithelium percentage using our color-based segmentation
method correlates well with pathologists' estimation of tissue epithelium percentages. The epithelium contents
estimated by color-based segmentation may be useful in immuno-based analysis or clinical proteomic analysis of
tumor proteins. The codes used for epithelium estimation as well as the micrographs with estimated epithelium
content are available online.
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The rapid advancement of high-throughput tools for
measurement of proteins from cancer tissues or body
fluids has demonstrated the potential for the identifica-
tion of proteins associated with diseases in all areas of
medicine. Most of these high-throughput tools utilize
either mass spectrometry (MS)-microarray-, or immuno-
sorbent assays for quantitative analysis of proteins [1].
With the advantage of quantitative measurement, cur-
rently, many protein assays with good sensitivity and
specificity have been developed for research and clinical
use in serum, urine and other body fluids. However, the
analysis of proteins in tissue specimens is limited to the
semi-quantitative immunohistochemistry (IHC) assay
that are required to obtain the tissue spatial information
and cell type-specific staining patterns. The usage of
quantitative protein assays such as MS, microarray, or
enzyme linked immunosorbent assay (ELISA) on tissue
specimens, however, has its limitations. Due to the loss
of spatial information, the measurements acquired are
usually confounded by tissue heterogeneity. Since tissue
specimens contain various types of cells, where the ex-
pressions of target proteins differ, protein assay results
become hard to interpret and may even be misleading.
With respect to cancer research, assessment of the ex-
pression of epithelial proteins is of great interest, since
over 90% of the carcinoma is of epithelial origin [2].
Compared to regions with normal tissue, regions with
cancer usually have significantly higher epithelium con-
tent yet lower stromal content. Depending on tumor
density, the epithelium to stroma ratio may vary consid-
erably and may influence protein quantitation readings
significantly when an epithelial protein is concerned, e.g.
a higher epithelial protein reading in tumor tissues
might be solely due to the increased epithelial content of
the epithelium rather than the biological overexpression
of that protein. Therefore, it would be important to con-
sider the epithelium content when we analyze the pro-
tein levels using quantitative protein assays.
There are a number of approaches to identify and
quantify epithelium content from histology slides. Trad-
itionally, the epithelium contents are read based on nu-
clei counts from a hematoxylin and eosin (H&E) stained
histology slide by a pathologist. Another approach is to
stain the histology slide with anti-cytokeratin antibody
CAM 5.2 (staining for epithelia) and Masson trichrome
(staining for collagenous stromal structures) [3]. More
recently, with the digitization of whole slide imaging, a
number of algorithms have been developed for com-
puter-assisted readings. These methods rely on image
features such as morphology, texture, color and intensity
to segment images and classify them into various patho-
logically different regions. Automated histopathological
image analysis reduces the inter-and intra-observererrors and provides additional quantitative information
to aid diagnosis [4]. However, to our knowledge, these
measurements have never been utilized for protein
measurements.
Epithelial cell adhesion molecule (EpCAM) and ca-
thepsin L (CTSL) are epithelial proteins that have been
found abundantly expressed in prostate adenocarcin-
omas [5,6]. EpCAM is a well known tumor associated
antigen and is expressed in various adenocarcinomas
and squamous cell carcinomas (e.g. prostate, lung, colon,
gastric carcinomas) [7-9]. Its expression on normal epi-
thelia, on the other hand, is rather variable yet much
lower than the carcinoma cells [10]. CTSL is a lysosomal
cystein proteinase that plays a major role in the catabol-
ism of intracellular and extracellular proteins [6]. Studies
on prostate cancer cell lines suggested that CTSL was
associated with the motility of prostate tumor cells and
therefore might be involved in tumor metastasis [11,12].
Although previous studies suggested an increase in
CTSL mRNA expression in prostate adenocarcinomas
[13], a recent study showed that CTSL staining in pros-
tate tissues is comparable between prostate adenocarcin-
omas and normal tissues [14].
In this study, we assessed EpCAM and CTSL levels
with ELISA in prostate cancer tissues and determined
the effect of epithelium content on tissue protein quanti-
tation. To determine the effect of tissue heterogeneity
on the interpretation of the ELISA result, we developed
an in-house color-based segmentation method for esti-
mation of epithelium content and applied the method
on ELISA results. A pathologist estimation of the epithe-
lium content was also applied on ELISA results. We
found that both EpCAM and CTSL levels, measured by
ELISA itself, were greatly affected by epithelium content
in the tissue specimens. However, after normalization by
epithelium percentage, ELISA measurements of both
EpCAM and CTSL were in agreement with IHC staining
results, demonstrating the need of normalization using
epithelium content in quantitative measurement of epi-
thelial proteins in tissue specimens.
Materials and methods
Materials
LSAB + Kits, biotin blocking system, antibody dilution
buffer were from Dako, Carpinteria, CA. Goat-anti-
CTSL antibody, antigen retrieval buffer, recombinant
protein, capture and detection antibody of human CTSL,
EpCAM, streptavidin-HRP conjugates and ELISA plates
were from R&D Systems, Minneapolis, MN. All other
chemicals were from Sigma-Aldrich (St. Louis, MO).
Clinical specimens
Samples and clinical information were obtained with in-
formed consent and performed with the approval of the
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sity. Formalin fixed paraffin embedded (FFPE) prostate
tissue slides were acquired for 6 individuals with primary
prostate tumors. Additional thirty-six OCT-embedded
prostate tumors were collected from radical prostatec-
tomy at Johns Hopkins Hospital and Johns Hopkins
Bayview Medical Center under the NCI-funded Johns
Hopkins prostate cancer SPORE project. These tumors
includes nineteen specimens with a Gleason score of 6,
seven specimens with a Gleason score of 7, five specimens
with a Gleason score of 8 and five specimens with a
Gleason score of 9 (Additional file 1: Table S1). Eight
OCT-embedded normal prostate tissues were collected
from healthy transplant donors. All specimens were snap-
frozen, embedded in OCT and stored at −80°C till use.
Immunohistochemical staining and tissue microarrays
IHC staining was performed on FFPE prostate tissue
slides from 6 individuals with primary prostate tumors.
Sections of tissue were deparaffinized and rehydrated.
Tissues were incubated in antigen retrieval buffer at
92-95°C for 10 min. CTSL was stained with Universal
LSAB™ + Kits per manufacture’s protocol. Briefly, tissues
were blocked by peroxidase block and 3% BSA/PBS for
30 min each followed by avidin and biotin block with
Biotin Blocking System for 15 min each at room
temperature. The tissues were then incubated with goat
anti-CTSL primary antibody in antibody dilution buffer
at 4 μg/mL followed by incubation with anti-goat
biotin labeled secondary antibody and high sensitivity
streptavidin-HRP for 30 min each. The CTSL staining
was detected with DAB chromogen.
Measurements of proteins from clinical specimens using
ELISA
The protein samples were collected by sectioning the
OCT-embedded frozen prostate tissues. The adjacent
sections of about every 15 tissue sections (6 μm each)
were stained with H&E for use in the computer-aided
and pathologist estimation of epithelium content. For
tumor specimens, the adjacent H&E slides were also
used for cryostat micro-dissection to enrich the tumor
tissue in the collected sample for immunoassay analysis.
Places where tissues were trimmed were marked in the
H&E slides and excluded for epithelium percentage esti-
mation. An estimated number of ten to twenty 6 μm-
thick tissue sections were collected in sterile screw-cap
bullet tubes for each sample for protein assays. Proteins
were then extracted from tissue sections using cell lysis
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.1% SDS,
0.5% Na Deoxycholate, 1% Triton × 100). BCA assay
was performed to determine and adjust the protein con-
centration for each tissue sample to 1 μg/mL with PBS.
Tissue EpCAM and CTSL levels were then measuredwith ELISA assay as described before [15]. Briefly, CTSL
(1 μg/mL) or EpCAM (4 μg/mL) capture antibody were
coated overnight in a 96-well plate. The wells were then
blocked with 3% BSA, incubated with 100 μL diluted
sample, with CTSL (0.5 μg/mL) or EpCAM (0.2 μg/mL)
biotinylated detection antibody for 1 h each, and with
streptavidin-HRP conjugates (1:200) for 30 min. The
assays were then developed with TMB substrate, stopped
with H2SO4 and measured by reading the plate at
450 nm with a spectrophotometer.
Estimation of epithelium ratio in prostate tissue
specimens
An in-house color-based segmentation method was de-
veloped for estimation of epithelial areas in prostate tis-
sue specimens using H&E stained face sections of
prostate tissues. For each of the 44 cases (36 tumors and
8 normal prostate tissues), digital slides were acquired
by scanning the H&E stained slide with AT Turbo
(Aperio technologies, Vista, CA.). Every 2.1 × 1.3 mm2
area of the micrograph was then saved into a .tiff file at
a resolution of 72 pixels per inch using the ImageScope
software (Aperio technologies, Vista, CA.) and an esti-
mated number of 13 ± 10 image files were generated for
each one of the 44 cases. One image from each case was
randomly selected to serve as the training image for the
classification algorithm and the rest of the images were
used as the test image set. The training images were
used as the input to the classification training code. All
computer simulations were implemented in MATLAB
(Mathworks, Natick, MA). Each training image was seg-
mented into four regions based on the pixel colors using
a k-means clustering algorithm. K-means clustering
algorithm is a clustering analysis tool for grouping a
number of observations into k clusters based on
the similarities between the observations. Briefly, the
observations were randomly assigned to clusters for
initialization and the centroid of each cluster was calcu-
lated. In an iterative manner, the cluster of each observa-
tion was updated to its nearest centroid and the
centroids of the clusters were re-calculated to reflect the
changes to the clusters, until the centroids converged to
the optimal values. In other words, each color cluster
was formed by minimizing the squared euclidean dis-
tance of the cluster members to its centroid. This will
group pixels with similar colors together in a color clus-
ter of white, bright pink, dark pink or purple in an H&E
stained slide where white, pink and purple correspond
to lumen, stroma and epithelium respectively. Each
micrograph was arranged into 20 × 20 pixel grids such
that each grid covered a 0.04 × 0.04 mm2 area of the tis-
sue section. The ratio of the area of the four colors to
the total area of the cell was calculated for each grid cell.
Clearly, the resultant four color ratios would sum to 1 in
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linearly independent. The epithelial regions of the ori-
ginal training image were manually marked by an experi-
enced researcher to serve as the benchmark for the
training of the classification algorithm. The marked epi-
thelial regions are shown by a green shade. The grid cells
were then divided into two groups based on whether
they were marked as epithelium or not and illustrated
on a scatterplot in the space of the three base colors of
the H&E micrographs. Any grid cell with white content
greater than 70% was marked as luminal. Knowing the
class of each of the grid cells based on the marked epi-
thelial regions, K-means clustering was again used to
divide the space of the three base colors into three clus-
ters representing the epithelial, stromal and luminal re-
gions. These clusters, established in the space of three
optionally selected color ratios, were then used to seg-
ment the images in the test dataset into epithelium,
stroma and lumen area, thus estimating the percentage
of each in the whole face section of prostate tissue. Seg-
mentation code worked similar to the training code as
the test image was segmented into four colors and theA
B
C
Figure 1 Immunohistochemical staining of prostate tumor tissues. Tu
L antibody and then counterstained with hematoxylin. Representative imag
ding hematoxylin and eosin stained reference images as shown in (D), (E)color ratios were calculated for each grid cell on the
image. Each grid cell was classified into epithelial,
stromal or luminal depending on its distance from the
established clusters in the space of the three color ratios.
The epithelium percentage was calculated by the follow-
ing formula: Epithelium area/(Epithelium area + Stroma
area) × 100%. The Matlab codes and H&E micrographs
used for epithelium estimation, as well as the micro-
graphs with estimated epithelium content are available
for download at http://sdrv.ms/17tWsqd.
Statistical analysis
Wilcoxon signed rank order test (unpaired, two-sided)
was used for determination of statistical significance of
EpCAM and CTSL immunoassay measurements.
Results
IHC staining of CTSL in prostate tissue specimens
To assess CTSL expression level in prostate tissue speci-
mens, IHC staining was performed on 6 FFPE prostate
tumor cases. Figure 1 shows representative fields of CTSL
stained and H&E stained slides from 3 representative casesD
E
F
mor tissue slides from 6 individuals were stained with anti-cathepsin
es from 3 individuals were shown in (A), (B), and (C) with correspon-
and (F).
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we found that CTSL stained epithelium with no staining
in the stroma compartment. Medium to strong staining of
CTSL was observed in all 6 prostate tumor cases. Hetero-
geneity in staining intensity was observed in both tumor
and adjacent normal epithelium. No differences in staining
intensity were observed between tumors and the adjacent
normal tissues. These results suggested that the expression
of CTSL in the prostate epithelium was similar between
normal and tumor tissues.
ELISA measurements of EpCAM and CTSL in prostate
tissue specimens
To measure EpCAM and CTSL level in prostate tissue
specimens, ELISA assays were developed for EpCAM
and CTSL. The limits of detection (LOD) calculated as
background OD ± 3SD were 188 and 27 pg/mL for
EpCAM and CTSL respectively; the dose responsive
ranges were from 0 to 2 ng/mL for both CTSL and
EpCAM (Figure 2A and B). At the lowest standard
point, the coefficients of variation (CV) were 0.78% and
6.3% for EpCAM and CTSL respectively. The intra-assay
CVs were 3.2% and 9.9% for EpCAM and CTSL respect-
ively. These assays were then used to analyze 8 normal
prostate tissues and 36 prostate tumors. The average
concentration of EpCAM was 9.39 ± 4.22 ng/mg total
protein for normal tissues and 44.61 ± 23.40 ng/mg for
prostate tumors (Figure 2C). The average concentrationFigure 2 Immunoassay measurements of epithelial cell adhesion mol
Standard curve of EpCAM. (B) Standard curve of CTSL. (C) EpCAM measure
tumors. (D) CTSL measurement of tissue lysate from 8 normal prostate tissu
prostate tissues.of CTSL measured was 6.30 ± 2.06 ng/mg total protein
for normal tissues and 11.83 ± 4.56 ng/mg total protein
for prostate tumors (Figure 2D). Compared to normal
tissues, immunoassay data showed that both EpCAM
and CTSL expression were significantly increased in
prostate tumors with a 4.75 fold increase for EpCAM
and a 1.88 fold increase for CTSL. However, as discussed
earlier, since tissue protein quantitation using ELISA
assay is influenced by both biological expression of the
target protein and the percentage of epithelial cells ex-
pressing the proteins, further analysis needs to be done
to determine the percentage of epithelial cells in order
to elucidate the biological expression of EpCAM and
CTSL between normal prostate tissues and prostate
tumors.
Estimation of epithelium percentage in prostate tissue
To account for the epithelium content of the tissue
specimens, we used two methods: 1) estimation of
epithelium content by a board certified pathologist;
2) estimation of epithelium content by a computer-aided
method. The H&E stained adjacent sections of all
44 cases where CTSL and EpCAM levels were measured
were analyzed for epithelium content with both
methods. For the computer aided method, we developed
an in-house color-based segmentation method. The 44
training H&E images, 1 from each case (Figure 3A),
were segmented into four colors representing theecule (EpCAM) and cathepsin L (CTSL) protein expression. (A)
ment of tissue lysate from 8 normal prostate tissues and 36 prostate
es and 36 prostate tumors. ***, p < 0.001, compared to normal
Figure 3 Color based segmentation and k-means clustering of grid cells into epithelial and non-epithelial regions based on color area
ratios. A representative micrograph of prostate tissue section at 20× (A) is segmented into four regions based on the pixel colors of (B) white,
(C) light pink, (D) dark pink and (E) purple, using a k-means clustering algorithm. (F) The epithelial areas of the training image were marked by
an experienced prostate cancer researcher and were arranged into 20 × 20 pixel grid cells. (G) The four color ratios were calculated in each grid
cell. Knowing the epithelial and non-epithelial regions in training sets, we classify the grid cells into two clusters. A scatter plot shows these
clusters in the space of three colors, which have small overlap.
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pink, Figure 3C and D) and epithelial (purple, Figure 3E)
regions of the tissues. Each image was then divided into
grid cells each covering 0.04 × 0.04 mm2 of the tissue
section (Figure 3F). The grid cells were already marked
by a researcher as epithelial or non-epithelial. Figure 3G
shows a scatter plot of the grid cells of Figure 3F in the
space of the three of the four H&E base colors (white,
light pink, dark pink and purple). Each dot represents
one of the grid cells, which depending on its color was
marked as epithelial (red) or non-epithelial (blue). The
three axes of the image stand for the proportion of the
pixels in each grid cell that fall into the corresponding
color cluster. The non-epithelial and epithelial cloud of
the dots in the defined three-dimensional space show
low overlap, suggesting that a clustering algorithm can
build clusters for classification of grid cells into epithelial
and non-epithelial according to the color ratios in the
cells. Therefore, the marked and unmarked grid cells on
the training image along with their color ratios were
used as inputs to the K-means clustering algorithm forgenerating the epithelial, stromal and luminal clusters in
the space of the three color ratios. These clusters, estab-
lished in the space of three optionally selected color
ratios, were then used to segment the images in the test
image set (13 ± 10 micrographs per case, 44 cases) into
epithelium, stroma and lumen area for calculation of
epithelium percentage.
Figure 4A and C shows a representative micrograph of
normal tissue and cancer specimen where the predicted
epithelium is highlighted in green. Figure 4B and D
shows the false positive and false negative regions,
marked in blue and magenta respectively. Cross-valida-
tion was performed on 44 micrographs from the training
image set (44 cases) to assess the accuracy of this epithe-
lium prediction method. For this analysis, 50% of the
grid cells of each of the training images were randomly
selected to form the training dataset for k-means cluster-
ing, while the remaining 50% of the cells were saved to
form the validation dataset for cross-validation to deter-
mine the accuracy of the method. According to cross-
validation results, the method predicted epithelium ratio
BA
DC
Marked Epithelial Area Ratio
E
Figure 4 Method output and cross-validation. The in-house color-based segmentation algorithm was implemented on micrographs of H&E
stained prostate tissue sections of 8 normal prostate tissues and 36 prostate tumors to segment the testing images into epithelial and non-
epithelial regions. The method output is depicted for a normal (A, B) and a cancerous (C, D) tissue sections. In the left column, the estimated
epithelial regions are highlighted in green. In the right column, the false positive and false negative regions are highlighted in blue and magenta,
respectively. The set of 44 H&E histology micrographs representing 44 cases was divided into training and validation datasets. The epithelial,
lumenal and stromal clusters were formed by analyzing the training set for each subject. The performance of the classifier was then evaluated by
examining the training and validation dataset. (E) The estimated and actual epithelial areas of the validation datasets were well correlated (R2 = 0.965).
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micrographs tested, the false positive rate was 8.79 ±
5.06% and the false negative rate was 8.12 ± 5.35%. Such
proximity of false positive and false negative rates
improves the estimation of total epithelial area. The
determination coefficient (R2) between the estimated
epithelium area and marked epithelial area in the valid-
ation set was 0.965 (Figure 4E).
Normalization of EpCAM and CTSL measurements with
estimated epithelium percentage
Subsequently, using the in-house developed method, we
estimated the epithelium percentage of the 8 normal
prostate tissues and 36 prostate tumors whose EpCAM
and CTSL levels were measured. The average epithelium
percentage in normal prostate tissues was 24.14 ± 5.58%
(Figure 5A). This ratio was similar to what was reportedbefore [3]. The average epithelium percentage in pros-
tate tumors was 57.98 ± 19.75%. As expected, the
epithelium percentage was significantly higher in tumors
compared to that in normal tissues. Similarly, the results
from pathologist estimation showed that epithelium per-
centage in normal prostate tissues was 33.75 ± 11.88%
with 62.36 ± 15.51% estimated for prostate tumors. The
computer aided and pathologist estimated epithelium per-
centages are statistically positively related (p < 0.001), with
a Pearson correlation coefficient of 0.72 (Figure 5B).
As EpCAM and CTSL are expressed in the prostatic
epithelium from IHC staining results, we used the epi-
thelium percentage to normalize the EpCAM and CTSL
ELISA results. After computer-aided normalization,
the average measured EpCAM was 39.11 ± 16.69
and 82.70 ± 39.56 ng/mg total protein/epithelium per-
centage for normal prostate tissues and prostate tumors
Figure 5 Immunoassay measurements of epithelial cell adhesion molecule (EpCAM) and cathepsin L (CTSL) protein expression after
normalization by epithelium percentage. (A) Epithelium percentage estimated for 8 normal and 36 cancer tissue slides with computer-aided
classification and pathologist estimation. (B) Scatter plot of computer-aided epithelium percentage estimated vs. pathologist estimation. (C)
EpCAM ELISA measurements were adjusted with epithelium percentage estimated with the computer-aided method. (D) CTSL ELISA measure-
ments were adjusted with epithelium percentage estimated with the computer aided method. (E) EpCAM ELISA measurements were adjusted
with epithelium percentage estimated by a pathologist. (F) CTSL ELISA measurements were adjusted with epithelium percentage estimated by a
pathologist. Corr: Pearson’s correlation coefficient. **, p < 0.01, compared to normal prostate tissue. ***, p < 0.001, compared to normal prostate tissue.
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was 27.27 ± 10.38 and 23.44 ± 12.80 ng/mg total protein/
epithelium percentage for normal prostate tissues and
prostate tumors (Figure 5D). After normalization by
the pathologist estimated epithelium percentage, the
average measured EpCAM was 32.02 ± 21.32 and
73.27 ± 34.12 ng/mg total protein/epithelium percentage
for normal prostate tissues and prostate tumors respect-
ively (Figure 5E); The average measured CTSL was
19.99 ± 7.78 and 20.74 ± 10.53 ng/mg total protein/epi-
thelium percentage for normal prostate tissues and
prostate tumors (Figure 5F). With both epithelium esti-
mations, EpCAM expression was significantly increased
in prostate tumors by about 2 fold, compared to the 4.75
fold increase without normalization (Figure 3C). In con-
trast to the significant elevated CTSL expression in pros-
tate tumors from ELISA results without normalization
by epithelial content (Figure 3D), CTSL expression wascomparable between normal tissues and prostate tumors
after epithelium normalization. These results are in agree-
ment with previous reports where IHC staining was used
to assess the protein expression of EpCAM and CTSL
[10,14], demonstrating the positive impact of epithelium
normalization in analyzing immunoassay results.
Discussion
Tissue specimen is a great source for identification of
disease related molecules, e.g. cancer related molecules/
markers. To evaluate protein expression in tissue
specimens, IHC staining is one of the most common
techniques utilized. IHC staining provides insight into
tissue heterogeneity, disease relevance of protein
markers, and the expression pattern of protein markers
in different cell types. However, IHC staining is subject
to inter-observer error and is at best semi-quantitative.
Direct measurements of proteins by mass spectrometry,
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are quantitative and can be standardized for quality
assurance. Consequently, use of immunosorbent assays
to measure protein expression in tissue specimens is
highly desirable if the result can be properly interpreted.
In this study, we introduced epithelial percentage
normalization as a tool in interpreting immunoassay
results for epithelial proteins. We developed a tool for
automated segmentation of micrograph slides into epi-
thelial and non-epithelial regions using k-means cluster-
ing. K-means clustering is one the fastest and simplest
clustering analysis tools that can reduce large datasets
into smaller, more manageable subspaces based on the
similarities observed in the dataset. The proposed epi-
thelial percentage estimation method segments the
image into four colors that are most dominant in typical
H&E micrograph slides. The four colors are determined
by the k-means clustering of the single pixels on each
micrograph. Therefore, although these colors are catego-
rized as white, light and dark pink and purple, they
might slightly vary from one slide to the other depend-
ing on the strength of the staining on each slide.
Subsequently, this method automatically accounts for
the variations between the color staining on different
tissue sections, which is a significant challenge in univer-
sal image processing of histology slides. In addition, this
algorithm achieved an accuracy of 84% on a database of
normal and prostate cancer tissue sections. The false
classification of 16% was almost equally divided between
the false positive and false negative results. Although the
false positive and negative results are not desirable and
must be minimized, in the context of epithelium per-
centage estimation, the inaccuracy introduced by false
classifications is cancelled out to a great degree. There-
fore, the equity of false positive and negative results ex-
plains the high correlation of the estimated epithelium
percentage with the marked epithelial percentage, which
is desirable for normalizing and interpreting the im-
munoassay for determining the biological changes in
protein expression.
It needs to be noted that to use epithelium percentage
estimation in epithelial protein measurement in tissue
specimens, the H&E stain needs to be representative of
the entire tissue that is studied for a given protein, and
the protein needs to be measured on the same exact
piece of tissue. This is because the range of epithelial to
stromal ratios on a given mass of tissue varies greatly de-
pending on the size of the tissue and the homogeneity of
the tissue structures (e.g. a given prostate cancer could
be 80% epithelial in some area and 5% in others). In this
study, to ensure the accuracy of epithelium percentage
estimated, adjacent H&E slide of approximately 15 sec-
tions of prostate tissues (6 μm each) was used for epithe-
lium estimation.With EpCAM and CTSL expressions in prostate
tumor tissues, we demonstrated that normalization by
epithelial percentage is useful in analyzing ELISA results
for epithelial proteins. With IHC staining carried out in
this study and in a previously published study [10,14],
we showed that CTSL expression was not significantly
different between normal tissue and prostate tumors
after epithelium normalization. While ELISA itself
misleadingly showed a significant increase of CTSL in
prostate tumors, with normalization by epithelium per-
centage, ELISA analysis also showed that CTSL expres-
sion was comparable between these two groups. EpCAM
was shown to be up-regulated in prostate carcinomas in
a number of studies with IHC staining [7-9]. In this
study, we also found a significant increase in EpCAM
with immunoassay analysis both with and without
normalization by epithelium percentage. However, the
difference of EpCAM expression between tumor and
normal tissues dropped significantly from 4.68 to around
2, which better depicted the biological differences of
EpCAM between tumor and normal cells.
In addition to facilitate analysisof ELISA results of epi-
thelial proteins, epithelium percentage estimation can
also be used in other quantitative assays (e.g. mRNA ex-
pression, protein activity assay, clinical proteomic ana-
lysis etc.) where spatial information is lost due to sample
homogenization to account for epithelium heterogeneity.
With epithelium percentage normalization, improve-
ment in the accuracy of biochemical measurements in
homogenized tissue specimens may be achieved. In
addition, by accounting for tissue heterogeneity, interest-
ing new protein markers may be identified. However,
further studies needs to be carried out in testing the
accuracy of epithelium percentage estimation.Conclusions
In summary, we developed an in-house color-based seg-
mentation method for estimation of epithelium content
and demonstrated the accuracy of the method in epithe-
lium estimation. Using EpCAM and CTSL as examples,
we demonstrated that protein expressions measured by
immunoassays correlate well with that measured IHC
staining, suggesting that normalization by epithelium
percentage is helpful in interpreting ELISA and similarly
other biochemical or proteomics based assay results.Additional file
Additional file 1: Table S1. Clinical information of normal prostate and
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